Clinical Trial Update: Study to Assess the Effect of Intravenous Supplementation of Omega-3 Fatty Acids on Outcome of Recipients in Living Donor Liver Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial investigating intravenous omega-3 fatty acid supplementation in recipients of living donor liver transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Liver Transplantation | Phase 2 | Status: UNKNOWN